[先天性纤维蛋白发育不良症:诊断和治疗的现状和挑战]
1Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
|December 2, 2024
概括
先天性纤维蛋白质血症 (CDF) 是一种常见的纤维素因子疾病,通常未被诊断出来. 患者可能面临出血,凝血或怀孕问题,突出需要更好的诊断和管理策略.
科学领域:
- 血液学 血液学 血液学
- 临床遗传学 临床遗传学
- 分子诊断学 分子诊断
背景情况:
- 先天性纤维蛋白质缺血症 (CDF) 是最常见的纤维蛋白质遗传性疾病,其特征是纤维蛋白质功能受损.
- 由于无症状病例和缺乏特定的诊断标准,其患病率可能被低估.
- 临床表现范围从出血到血栓事件和妊娠并发症.
研究的目的:
- 审查当前对先天性纤维蛋白发育不良症的理解.
- 突出诊断挑战和临床管理方面的考虑.
- 强调需要进一步的研究和改善患者分层的需要.
主要方法:
- 对有关先天性纤维蛋白质变异性血症的现有文献的综述.
- 对诊断方法的分析,包括纤维素抗原测定和遗传测试.
- 讨论临床表现和管理策略.
主要成果:
- CDF呈现出不同的临床表型,包括出血,血栓形成和产科并发症.
- 将CDF与其他遗传性纤维素原异常区分开来,取决于纤维素原抗原水平和家族研究.
- 目前的实验室方法缺乏对出血或血栓形成风险的常规预测能力.
结论:
- 准确的诊断和先天性纤维蛋白发育不良的风险分层仍然具有挑战性.
- 个人和家庭病史至关重要,但不足以预测患者的结果.
- 展望性和基于注册表的研究对于推进CDF的临床管理至关重要.
相关概念视频
Disorders of Hemostasis
707
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
707
Inborn Errors of Metabolism
127
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
127
Rh Blood Group
1.3K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.3K
Cystic Fibrosis: Management
141
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
141
Anticoagulant Drugs: Low-Molecular-Weight Heparins
616
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
616
Pedigree Analysis
84.0K
Overview
84.0K


